
NATR Stock Forecast & Price Target
NATR Analyst Ratings
Bulls say
Natures Sunshine Products Inc. has demonstrated robust financial performance, with projected sales of $480.1 million for 2025, reflecting a 5.7% increase at the high end of management guidance, indicating strong demand for their health and wellness offerings. The fourth quarter of 2025 saw sales rise by 4.7% to $123.8 million, complemented by a gross margin improvement of 190 basis points year over year, driven by effective cost-saving initiatives and favorable product mix. Additionally, the company experienced notable growth in the European market, with sales increasing by 10% in constant currency due to improved execution and product availability, contributing to a positive outlook for continued expansion in key regions.
Bears say
Natures Sunshine Products Inc. has experienced a slight decline in sales, particularly in the Asia Pacific region, with a year-over-year decrease of 1.0% attributed to challenging comparisons from a strong previous quarter. The company faces potential risks related to its ability to innovate and adapt to changing consumer preferences, which could adversely affect future sales if new products do not resonate with the market. Additionally, the company's positioning in the higher-cost sector of the vitamins and supplements market could hinder growth as consumers may shift towards more affordable options amid ongoing economic pressures.
This aggregate rating is based on analysts' research of Nature's Sunshine Products and is not a guaranteed prediction by Public.com or investment advice.
NATR Analyst Forecast & Price Prediction
Start investing in NATR
Order type
Buy in
Order amount
Est. shares
0 shares